Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Mar-24 6:26 PM View:  | Agilent Technologies Inc. (A) | 15-Mar-24 | Grant | 1,678 | $147.48 | $247,471.00 | 5% 34.76K to 36.44K | (2%) |
| 26-Feb-24 7:30 PM View: | Vir Biotechnology, Inc. (VIR) | 26-Feb-24 | Sale (Planned) | 17,722 | $11.65 | $206,522.00 | (< 1%) 3.84M to 3.83M | |
| 26-Feb-24 7:30 PM View: | Vir Biotechnology, Inc. (VIR) | 22-Feb-24 | Sale | 10,028 | $10.05 | $100,737.00 | (< 1%) 3.85M to 3.84M | |
| 20-Feb-24 9:02 PM View: | Vir Biotechnology, Inc. (VIR) | 20-Feb-24 | Sale (Planned) | 16,872 | $10.22 | $172,385.00 | (< 1%) 3.87M to 3.85M | |
| 20-Feb-24 9:02 PM View: | Vir Biotechnology, Inc. (VIR) | 16-Feb-24 | Sale | 10,878 | $10.24 | $111,386.00 | (< 1%) 3.88M to 3.87M | |
| 18-Oct-23 2:14 PM View: | Vir Biotechnology, Inc. (VIR) | 17-Oct-23 | Acquisition (other) | 3,500,000 | -- | -- | 90% 3.88M to 7.38M | |
| 18-Oct-23 2:14 PM View: | Vir Biotechnology, Inc. (VIR) | 17-Oct-23 | Disposition (other) | 1,750,000 | -- | -- | (24%) 7.38M to 5.63M | |
| 18-Oct-23 2:14 PM View: | Vir Biotechnology, Inc. (VIR) | 17-Oct-23 | Disposition (other) | 1,750,000 | -- | -- | (31%) 5.63M to 3.88M | |
| 18-Sep-23 3:54 PM View: | Vir Biotechnology, Inc. (VIR) | 15-Sep-23 | Acquisition (other) | 1,750,000 | -- | -- | 30% 5.76M to 7.51M | |
| 18-Sep-23 3:54 PM View: | Vir Biotechnology, Inc. (VIR) | 15-Sep-23 | Acquisition (other) | 1,750,000 | -- | -- | 23% 7.51M to 9.26M | |
| 18-Sep-23 3:54 PM View: | Vir Biotechnology, Inc. (VIR) | 15-Sep-23 | Disposition (other) | 5,377,590 | -- | -- | (58%) 9.26M to 3.88M | |
| 20-Mar-23 9:41 PM View: | Agilent Technologies Inc. (A) | 16-Mar-23 | Grant | 1,658 | $136.82 | $226,848.00 | 5% 32.98K to 34.63K | 6% |
| 24-Feb-23 8:34 PM View: | Vir Biotechnology, Inc. (VIR) | 24-Feb-23 | Sale (Planned) | 15,119 | $23.33 | $352,682.00 | (< 1%) 5.77M to 5.76M | |
| 24-Feb-23 8:34 PM View: | Vir Biotechnology, Inc. (VIR) | 23-Feb-23 | Sale | 12,631 | $25.97 | $328,065.00 | (< 1%) 5.79M to 5.77M | |
| 21-Feb-23 7:29 PM View: | Vir Biotechnology, Inc. (VIR) | 21-Feb-23 | Sale (Planned) | 17,856 | $28.30 | $505,318.00 | (< 1%) 5.81M to 5.79M | |
| 21-Feb-23 7:29 PM View: | Vir Biotechnology, Inc. (VIR) | 17-Feb-23 | Sale | 9,894 | $25.29 | $250,199.00 | (< 1%) 5.82M to 5.81M | |
| 21-Feb-23 7:29 PM View: | Vir Biotechnology, Inc. (VIR) | 18-Jan-23 | Acquisition (other) | 64,930 | -- | -- | 1% 5.82M to 5.88M | |
| 21-Feb-23 7:29 PM View: | Vir Biotechnology, Inc. (VIR) | 18-Jan-23 | Disposition (other) | 64,930 | -- | -- | (1%) 5.88M to 5.82M | |
| 21-Feb-23 7:29 PM View: | Vir Biotechnology, Inc. (VIR) | 21-Dec-22 | Acquisition (other) | 99,968 | -- | -- | 2% 5.82M to 5.92M | |
| 21-Feb-23 7:29 PM View: | Vir Biotechnology, Inc. (VIR) | 21-Dec-22 | Disposition (other) | 99,968 | -- | -- | (2%) 5.92M to 5.82M | |
| 21-Mar-22 5:12 PM View: | Agilent Technologies Inc. (A) | 17-Mar-22 | Grant | 1,785 | $136.82 | $244,224.00 | 6% 31.09K to 32.87K | 6% |
| 06-Apr-22 5:22 PM View: | Vir Biotechnology, Inc. (VIR) | 10-Mar-22 | Grant | 111,000 | -- | -- | 2% 5.7M to 5.82M | |
| 22-Feb-22 5:01 PM View: | Vir Biotechnology, Inc. (VIR) | 18-Feb-22 | Market Sale (Planned) | 17,726 | $30.65 | $543,304.00 | (< 1%) 5.72M to 5.7M | (9%) |
| 22-Feb-22 5:01 PM View: | Vir Biotechnology, Inc. (VIR) | 17-Feb-22 | Market Sale | 10,024 | $31.93 | $320,074.00 | (< 1%) 5.73M to 5.72M | (5%) |
| 14-Feb-22 10:00 PM View: | Vir Biotechnology, Inc. (VIR) | 07-Sep-21 | Gift | 1,877,590 | -- | -- | 33% 5.73M to 7.61M | |
| 14-Feb-22 10:00 PM View: | Vir Biotechnology, Inc. (VIR) | 07-Sep-21 | Gift | 29,739 | -- | -- | < 1% 7.61M to 7.64M | |
| 14-Feb-22 10:00 PM View: | Vir Biotechnology, Inc. (VIR) | 07-Sep-21 | Gift | 1,907,330 | -- | -- | (25%) 7.64M to 5.73M | |
| 14-Feb-22 10:00 PM View: | Vir Biotechnology, Inc. (VIR) | 01-Apr-21 | Gift | 3,598,560 | -- | -- | 63% 5.73M to 9.33M | |
| 14-Feb-22 10:00 PM View: | Vir Biotechnology, Inc. (VIR) | 01-Apr-21 | Gift | 3,598,560 | -- | -- | (39%) 9.33M to 5.73M | |
| 22-Mar-21 3:26 PM View: | Agilent Technologies Inc. (A) | 18-Mar-21 | Grant | 2,836 | $121.59 | $344,838.00 | 10% 28.16K to 30.99K | < 1% |
| 18-Feb-21 5:01 PM View: | Vir Biotechnology, Inc. (VIR) | 16-Feb-21 | Grant | 111,000 | -- | -- | 2% 6.52M to 6.63M | |
| 14-Feb-22 10:00 PM View: | Vir Biotechnology, Inc. (VIR) | 16-Feb-21 | Gift | 900,000 | -- | -- | (14%) 6.63M to 5.73M | |
| 12-Feb-21 10:00 PM View: | Vir Biotechnology, Inc. (VIR) | 28-Dec-20 | Gift | 100,000 | -- | -- | (2%) 6.62M to 6.52M | |
| 12-Feb-21 10:00 PM View: | Vir Biotechnology, Inc. (VIR) | 02-Dec-20 | Gift | 115,000 | -- | -- | 2% 6.62M to 6.74M | |
| 12-Feb-21 10:00 PM View: | Vir Biotechnology, Inc. (VIR) | 02-Dec-20 | Gift | 115,000 | -- | -- | (2%) 6.74M to 6.62M | |
| 05-Aug-20 6:32 PM View: | Agilent Technologies Inc. (A) | 03-Aug-20 | Grant | 177 | $93.91 | $16,622.10 | < 1% 27.93K to 28.11K | |
| 20-May-20 8:35 PM View: | Exelixis, Inc. (EXEL) | 18-May-20 | Market Sale (Planned) | 75,000 | $25.96 | $1,947,000.00 | (9%) 813.31K to 738.31K | |
| 15-May-20 8:31 PM View: | Exelixis, Inc. (EXEL) | 15-May-20 | Option Exercise | 51,686 | $5.10 | $263,613.00 | 7% 761.63K to 813.31K | |
| 24-Apr-20 8:24 PM View: | Exelixis, Inc. (EXEL) | 24-Apr-20 | Market Sale (Planned) | 15,000 | $26.24 | $393,600.00 | (2%) 776.63K to 761.63K | |
| 24-Apr-20 8:24 PM View: | Exelixis, Inc. (EXEL) | 23-Apr-20 | Market Sale (Planned) | 100,000 | $25.99 | $2,598,640.00 | (11%) 876.63K to 776.63K | |
| 22-Apr-20 8:50 PM View: | Exelixis, Inc. (EXEL) | 22-Apr-20 | Market Sale (Planned) | 4,200 | $25.05 | $105,210.00 | (< 1%) 880.83K to 876.63K | |
| 22-Apr-20 8:50 PM View: | Exelixis, Inc. (EXEL) | 21-Apr-20 | Market Sale (Planned) | 5,800 | $25.04 | $145,232.00 | (< 1%) 886.63K to 880.83K | |
| 22-Apr-20 8:50 PM View: | Exelixis, Inc. (EXEL) | 20-Apr-20 | Market Sale (Planned) | 50,000 | $23.89 | $1,194,640.00 | (5%) 936.63K to 886.63K | |
| 21-Apr-20 7:46 PM View: | Agilent Technologies Inc. (A) | 17-Apr-20 | Grant | 4,108 | $73.01 | $299,921.00 | 17% 23.78K to 27.89K | (4%) |
| 17-Apr-20 8:11 PM View: | Exelixis, Inc. (EXEL) | 15-Apr-20 | Market Sale (Planned) | 25,000 | $18.31 | $457,750.00 | (3%) 961.63K to 936.63K | (9%) |
| 16-Apr-20 5:33 PM View: | Vir Biotechnology, Inc. (VIR) | 14-Apr-20 | Acquisition (other) | 236,806 | $29.56 | $6,999,980.00 | 4% 6.62M to 6.86M | |
| 16-Apr-20 5:33 PM View: | Vir Biotechnology, Inc. (VIR) | 14-Apr-20 | Disposition (other) | 236,806 | $29.56 | $6,999,980.00 | (3%) 6.86M to 6.62M | |
| 09-Apr-20 8:20 PM View: | Exelixis, Inc. (EXEL) | 08-Apr-20 | Market Sale (Planned) | 7,065 | $18.35 | $129,643.00 | (< 1%) 968.69K to 961.63K | (9%) |
| 09-Apr-20 8:20 PM View: | Exelixis, Inc. (EXEL) | 07-Apr-20 | Market Sale (Planned) | 16,435 | $18.25 | $299,939.00 | (2%) 985.13K to 968.69K | (9%) |
| 02-Apr-20 8:08 PM View: | Exelixis, Inc. (EXEL) | 31-Mar-20 | Market Sale (Planned) | 1,500 | $18.06 | $27,090.00 | (< 1%) 986.63K to 985.13K | (10%) |